Loading...

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study

BACKGROUND: COPD-related deaths are increasing in Japan, with ~5.3 million people at risk. METHODS: The SHINE was a 26-week, multicenter, randomized, double-blind, parallel-group study that evaluated safety and efficacy of indacaterol (IND)/glycopyrronium (GLY) 110/50 μg once daily (od) compared wit...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Chron Obstruct Pulmon Dis
Main Authors: Hashimoto, Shu, Ikeuchi, Hisataro, Murata, Shujiro, Kitawaki, Tetsuji, Ikeda, Kimitoshi, Banerji, Donald
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5066848/
https://ncbi.nlm.nih.gov/pubmed/27785010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S111408
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!